CD44 is increasingly recognized as a marker for subpopulations of cancer stem cells (CSCs) that are highly malignant and chemoresistant.84, 85 The CD44/hyaluronic acid interaction has been investigated in many tumor models, and the results have been promising.86, 87 Somasunderam et al. The gene discussed is CD44; the disease is neoplasm.